Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
ASCO: Merck bills Keytruda, used around surgery, as new standard in 'messy' early lung cancer realm
Fierce Pharma
Sun, 06/4/23 - 04:22 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
non-small cell lung cancer
FDA clears narrow use of Lynparza in prostate cancer, continuing ‘shift’ on PARP drugs
BioPharma Dive
Thu, 06/1/23 - 11:49 am
Tags:
AstraZeneca
,
Merck
,
Lynparza
,
prostate cancer
,
FDA
Merck study: mRNA technology a ‘game changer’ for Asia-Pacific vaccine manufacturers
Biopharma Reporter
Wed, 05/31/23 - 11:10 am
Tags:
vaccines
,
MRNA
,
Merck
,
Asia-Pacific
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
Tags:
FDA
,
Albireo Pharma
,
Aldeyra Therapeutics
,
Alvotech
,
Amneal Pharmaceuticals
,
Argenx
,
ARS Pharmaceuticals
,
AstraZeneca
,
Bayer
,
Bio-Thera Solutions
,
Biogen
,
BioMarin Pharmaceutical
,
Bristol Myers Squibb
,
Eisai
,
Eton Pharmaceuticals
,
F2G
,
Fabre-Kramer Pharmaceuticals
,
Fresenius
,
GSK
,
Intercept Pharmaceuticals
,
Ipsen
,
Ironwood Pharmaceuticals
,
Merck
,
Novaliq
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
,
Sarepta Therapeutics
,
Shionogi
,
Swedish Orphan Biovitrum
,
Takeda
,
Teva Pharmaceutica
,
UCB Pharma
Merck and Eisai tease results for renal carcinoma treatment
Clinical Trials Arena
Tue, 05/30/23 - 09:18 pm
Tags:
Merck
,
Eisai
,
ASCO 2023
,
Lenvima
,
Keytruda
,
renal cell carcinoma
ASCO puts spotlight on advancing antibody-drug conjugate pipeline
BioPharma Dive
Thu, 05/25/23 - 08:51 pm
Tags:
ASCO 2023
,
antibody-drug conjugate
,
Merck
,
BioNTech
,
Daiichi Sankyo
ASCO: Merck gives final look at Keytruda study in first-line cervical cancer. Will FDA change its mind?
Fierce Pharma
Thu, 05/25/23 - 08:37 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
cervical cancer
ASCO preview: Merck's Keytruda, Novartis' Kisqali face their moment of truth in early-stage cancers
Fierce Pharma
Thu, 05/25/23 - 08:33 pm
Tags:
ASCO 2023
,
Merck
,
Keytruda
,
Novartis
,
Kisqali
,
non-small cell lung cancer
,
early breast cancer
Merck’s Gardasil Under Legal Scrutiny Despite Lack of Evidence to Support Suits
BioSpace
Wed, 05/24/23 - 10:15 am
Tags:
Merck
,
vaccines
,
Gardasil
,
legal
,
HPV
,
side effects
Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic
Medical Xpress
Wed, 05/17/23 - 10:53 pm
Tags:
Merck
,
antibiotics
,
Recarbrio
,
FDA
,
BMJ
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
Tags:
M&A
,
antitrust
,
Amgen
,
Astellas
,
Bellus Health
,
Globus Medical
,
GSK
,
Horizon Therapeutics
,
Merck
,
NuVasive
,
Pfizer
,
Prometheus Biosciences
,
Seagen
Hummingbird and Merck to evaluate combination therapy for NSCLC
Clinical Trials Arena
Mon, 05/15/23 - 06:19 pm
Tags:
Merck
,
Hummingbird Bioscience
,
HMBD-001
,
cetuxumab
,
squamous non-small cell lung cancer
The waxing and waning of the speedy approval
EP Vantage
Mon, 05/15/23 - 09:58 am
Tags:
FDA
,
drug approvals
,
accelerated approvals
,
AbbVie
,
AstraZeneca
,
Bayer
,
Bristol Myers Squibb
,
JNJ
,
Merck
,
Merck KGaA
,
Novartis
,
Pfizer
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Tags:
Gilead Sciences
,
GSK
,
momelotinib
,
Roche
,
Eli Lilly
,
lebrikizumab
,
Merck
,
Zejula
,
Amgen
,
Galenica
,
Veltassa
,
Cubicin
Gossamer cuts loose 25% of its staff, ties future to phase 3 trial of tarnished Merck rival
Fierce Biotech
Wed, 05/10/23 - 10:10 am
Tags:
Gossamer Bio
,
layoffs
,
seralutinib
,
Merck
,
PAH
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
Tags:
AbbVie
,
Amgen
,
AstraZeneca
,
Bristol Myers Squibb
,
Daiichi Sankyo
,
Eli Lilly
,
Gilead Sciences
,
Horizon Therapeutics
,
Merck
,
Moderna Therapeutics
,
Novartis
,
Novo Nordisk
,
Pfizer
,
Regeneron
,
Roche
,
Sanofi
Biopharma Bets Big on Antibody-Drug Conjugates
BioSpace
Mon, 05/8/23 - 10:20 am
Tags:
antibody-drug conjugate
,
Merck
,
Seagen
,
M&A
,
AstraZeneca
,
BioNTech
,
Bristol Myers Squibb
Merck bets big on PRA023 with $10.8bn Prometheus acquisition offer
Clinical Trials Arena
Wed, 05/3/23 - 10:37 pm
Tags:
Merck
,
Prometheus Biosciences
,
PRA023
,
ulcerative colitis
Merck entitled to $1.4B in cyberattack case after court rejects insurers' 'warlike action' claim
Fierce Pharma
Tue, 05/2/23 - 11:43 am
Tags:
Merck
,
legal
,
cybersecurity
,
cyberattacks
AbbVie, Bristol Myers vied for Prometheus before Merck bought it
Crain's Chicago Business
Mon, 05/1/23 - 10:15 pm
Tags:
Merck
,
Prometheus Biosciences
,
M&A
,
AbbVie
,
Bristol Myers Squibb
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
cafepharma is a: rock, tree, site
*
Fill in the blank.